Compare CLDX & WLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | WLY |
|---|---|---|
| Founded | N/A | 1807 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Books |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2008 | N/A |
| Metric | CLDX | WLY |
|---|---|---|
| Price | $25.87 | $30.95 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $44.10 | N/A |
| AVG Volume (30 Days) | 718.4K | ★ 744.3K |
| Earning Date | 11-10-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 4.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.87 |
| Revenue | $2,599,000.00 | ★ $1,665,756,000.00 |
| Revenue This Year | N/A | $0.86 |
| Revenue Next Year | $19.70 | $2.66 |
| P/E Ratio | ★ N/A | $16.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.40 | $29.93 |
| 52 Week High | $30.50 | $47.26 |
| Indicator | CLDX | WLY |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 35.77 |
| Support Level | $24.97 | $30.75 |
| Resistance Level | $28.79 | $31.97 |
| Average True Range (ATR) | 1.36 | 1.69 |
| MACD | -0.36 | -0.13 |
| Stochastic Oscillator | 16.46 | 10.66 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.